Cargando…

Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin

AIMS/HYPOTHESIS: The action of incretin hormones including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) is potentiated in animal models defective in glucagon action. It has been reported that such animal models maintain normoglycaemia under streptozotocin (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Iida, Atsushi, Seino, Yusuke, Fukami, Ayako, Maekawa, Ryuya, Yabe, Daisuke, Shimizu, Shinobu, Kinoshita, Keita, Takagi, Yusuke, Izumoto, Takako, Ogata, Hidetada, Ishikawa, Kota, Ozaki, Nobuaki, Tsunekawa, Shin, Hamada, Yoji, Oiso, Yutaka, Arima, Hiroshi, Hayashi, Yoshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901104/
https://www.ncbi.nlm.nih.gov/pubmed/27053237
http://dx.doi.org/10.1007/s00125-016-3935-2
_version_ 1782436744824619008
author Iida, Atsushi
Seino, Yusuke
Fukami, Ayako
Maekawa, Ryuya
Yabe, Daisuke
Shimizu, Shinobu
Kinoshita, Keita
Takagi, Yusuke
Izumoto, Takako
Ogata, Hidetada
Ishikawa, Kota
Ozaki, Nobuaki
Tsunekawa, Shin
Hamada, Yoji
Oiso, Yutaka
Arima, Hiroshi
Hayashi, Yoshitaka
author_facet Iida, Atsushi
Seino, Yusuke
Fukami, Ayako
Maekawa, Ryuya
Yabe, Daisuke
Shimizu, Shinobu
Kinoshita, Keita
Takagi, Yusuke
Izumoto, Takako
Ogata, Hidetada
Ishikawa, Kota
Ozaki, Nobuaki
Tsunekawa, Shin
Hamada, Yoji
Oiso, Yutaka
Arima, Hiroshi
Hayashi, Yoshitaka
author_sort Iida, Atsushi
collection PubMed
description AIMS/HYPOTHESIS: The action of incretin hormones including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) is potentiated in animal models defective in glucagon action. It has been reported that such animal models maintain normoglycaemia under streptozotocin (STZ)-induced beta cell damage. However, the role of GIP in regulation of glucose metabolism under a combination of glucagon deficiency and STZ-induced beta cell damage has not been fully explored. METHODS: In this study, we investigated glucose metabolism in mice deficient in proglucagon-derived peptides (PGDPs)—namely glucagon gene knockout (GcgKO) mice—administered with STZ. Single high-dose STZ (200 mg/kg, hSTZ) or moderate-dose STZ for five consecutive days (50 mg/kg × 5, mSTZ) was administered to GcgKO mice. The contribution of GIP to glucose metabolism in GcgKO mice was also investigated by experiments employing dipeptidyl peptidase IV (DPP4) inhibitor (DPP4i) or Gcg–Gipr double knockout (DKO) mice. RESULTS: GcgKO mice developed severe diabetes by hSTZ administration despite the absence of glucagon. Administration of mSTZ decreased pancreatic insulin content to 18.8 ± 3.4 (%) in GcgKO mice, but ad libitum-fed blood glucose levels did not significantly increase. Glucose-induced insulin secretion was marginally impaired in mSTZ-treated GcgKO mice but was abolished in mSTZ-treated DKO mice. Although GcgKO mice lack GLP-1, treatment with DPP4i potentiated glucose-induced insulin secretion and ameliorated glucose intolerance in mSTZ-treated GcgKO mice, but did not increase beta cell area or significantly reduce apoptotic cells in islets. CONCLUSIONS/INTERPRETATION: These results indicate that GIP has the potential to ameliorate glucose intolerance even under STZ-induced beta cell damage by increasing insulin secretion rather than by promoting beta cell survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-016-3935-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-4901104
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-49011042016-06-27 Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin Iida, Atsushi Seino, Yusuke Fukami, Ayako Maekawa, Ryuya Yabe, Daisuke Shimizu, Shinobu Kinoshita, Keita Takagi, Yusuke Izumoto, Takako Ogata, Hidetada Ishikawa, Kota Ozaki, Nobuaki Tsunekawa, Shin Hamada, Yoji Oiso, Yutaka Arima, Hiroshi Hayashi, Yoshitaka Diabetologia Article AIMS/HYPOTHESIS: The action of incretin hormones including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) is potentiated in animal models defective in glucagon action. It has been reported that such animal models maintain normoglycaemia under streptozotocin (STZ)-induced beta cell damage. However, the role of GIP in regulation of glucose metabolism under a combination of glucagon deficiency and STZ-induced beta cell damage has not been fully explored. METHODS: In this study, we investigated glucose metabolism in mice deficient in proglucagon-derived peptides (PGDPs)—namely glucagon gene knockout (GcgKO) mice—administered with STZ. Single high-dose STZ (200 mg/kg, hSTZ) or moderate-dose STZ for five consecutive days (50 mg/kg × 5, mSTZ) was administered to GcgKO mice. The contribution of GIP to glucose metabolism in GcgKO mice was also investigated by experiments employing dipeptidyl peptidase IV (DPP4) inhibitor (DPP4i) or Gcg–Gipr double knockout (DKO) mice. RESULTS: GcgKO mice developed severe diabetes by hSTZ administration despite the absence of glucagon. Administration of mSTZ decreased pancreatic insulin content to 18.8 ± 3.4 (%) in GcgKO mice, but ad libitum-fed blood glucose levels did not significantly increase. Glucose-induced insulin secretion was marginally impaired in mSTZ-treated GcgKO mice but was abolished in mSTZ-treated DKO mice. Although GcgKO mice lack GLP-1, treatment with DPP4i potentiated glucose-induced insulin secretion and ameliorated glucose intolerance in mSTZ-treated GcgKO mice, but did not increase beta cell area or significantly reduce apoptotic cells in islets. CONCLUSIONS/INTERPRETATION: These results indicate that GIP has the potential to ameliorate glucose intolerance even under STZ-induced beta cell damage by increasing insulin secretion rather than by promoting beta cell survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-016-3935-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2016-04-06 2016 /pmc/articles/PMC4901104/ /pubmed/27053237 http://dx.doi.org/10.1007/s00125-016-3935-2 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Iida, Atsushi
Seino, Yusuke
Fukami, Ayako
Maekawa, Ryuya
Yabe, Daisuke
Shimizu, Shinobu
Kinoshita, Keita
Takagi, Yusuke
Izumoto, Takako
Ogata, Hidetada
Ishikawa, Kota
Ozaki, Nobuaki
Tsunekawa, Shin
Hamada, Yoji
Oiso, Yutaka
Arima, Hiroshi
Hayashi, Yoshitaka
Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin
title Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin
title_full Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin
title_fullStr Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin
title_full_unstemmed Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin
title_short Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin
title_sort endogenous gip ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901104/
https://www.ncbi.nlm.nih.gov/pubmed/27053237
http://dx.doi.org/10.1007/s00125-016-3935-2
work_keys_str_mv AT iidaatsushi endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT seinoyusuke endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT fukamiayako endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT maekawaryuya endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT yabedaisuke endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT shimizushinobu endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT kinoshitakeita endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT takagiyusuke endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT izumototakako endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT ogatahidetada endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT ishikawakota endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT ozakinobuaki endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT tsunekawashin endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT hamadayoji endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT oisoyutaka endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT arimahiroshi endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin
AT hayashiyoshitaka endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin